液态血浆:优化大量输血中早期平衡血浆复苏的解决方案
本研究基于一级创伤中心的创伤质量改进项目数据,评估2016至2018年间大量输血方案激活患者,比较实施A型液态血浆(2017年4月后)与仅使用解冻新鲜冰冻血浆(之前)的差异。共纳入95例患者(液态血浆前39例,后56例)。实施液态血浆后,初始血浆输注时间和4、24小时血浆/红细胞比值改善,红细胞输注单位减少(p<0.05)。28天Cox回归显示液态血浆实施与有利恢复相关(HR 3.16,95%CI 1.60-6.24,p<0.001),并减少急性肾损伤(HR 0.092,95%CI 0.011-0.77,p=0.027)。作者认为液态血浆应作为大量输血方案中新鲜冰冻血浆的替代选择。
要点
- 在大量输血方案中使用A型液态血浆替代解冻新鲜冰冻血浆,可改善初始血浆输注时间和4、24小时血浆/红细胞比值,并减少红细胞输注单位(p<0.05)。
- 液态血浆实施与28天有利恢复相关(HR 3.16,95%CI 1.60-6.24,p<0.001)。
- 液态血浆实施与急性肾损伤减少相关(HR 0.092,95%CI 0.011-0.77,p=0.027)。
- 9例B型或AB型血患者接受A型液态血浆后24小时内未显示溶血证据。
- 作者认为液态血浆应作为大量输血方案中新鲜冰冻血浆的替代选择考虑。
适用人群与场景
- 一级创伤中心中激活大量输血方案的严重创伤患者。
处置流程与药物剂量
- 在大量输血方案中使用A型液态血浆替代解冻新鲜冰冻血浆进行初始复苏。
研究设计与关键结果
- 研究类型为基于创伤质量改进项目数据的回顾性分析(原文未明确写回顾性,但为前后对比的质量改进项目数据),纳入2016至2018年一级创伤中心大量输血方案激活患者95例,其中液态血浆实施前39例、实施后56例。
- 实施液态血浆后初始血浆输注时间和4、24小时血浆/红细胞比值改善,同时红细胞输注单位减少(p<0.05)。
- 28天Cox比例风险回归显示液态血浆实施与有利恢复相关(HR 3.16,95%CI 1.60-6.24,p<0.001)。
- 28天Cox比例风险回归显示液态血浆实施与急性肾损伤减少相关(HR 0.092,95%CI 0.011-0.77,p=0.027)。
- 9例B型或AB型血患者接受A型液态血浆后24小时内未显示溶血证据。
证据类型、等级与局限
- 证据类型为治疗/临床管理研究,证据等级为level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为液态血浆应作为大量输血方案中新鲜冰冻血浆的替代选择考虑。
- 在大量输血方案中可使用A型液态血浆以优化早期血浆给予并提高输血比值指南的依从性。
- 对B型或AB型血患者使用A型液态血浆时,本研究9例患者24小时内未观察到溶血证据。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Early and balanced resuscitation for traumatic hemorrhagic shock is associated with decreased mortality, making timely plasma administration imperative. However, fresh frozen plasma (FFP) thaw time can delay administration, and the shelf life of thawed FFP limits supply and may incur wastage. Liquid plasma (LP) offers an attractive alternative given immediate transfusion potential and extended shelf life. As such, we hypothesized that the use of LP in the massive transfusion protocol (MTP) would improve optimal plasma/red blood cell (RBC) ratios, initial plasma transfusion times, and clinical outcomes in the severely injured patient.
METHODS: Using Trauma Quality Improvement Program data from our level 1 trauma center, we evaluated MTP activations from 2016 to 2018. Type A LP use was instated April 2017. Before this, thawed FFP was solely used. Plasma/RBC ratios and initial plasma transfusion times were compared in MTP patients before and after LP implementation. Patient and injury characteristics were accounted for using linear regression analysis. Secondary outcomes of mortality, 28-day recovery, and complications were evaluated using Cox proportional hazards regression.
RESULTS: A total of 95 patients were included (pre-LP, 39; post-LP, 56). Time to initial plasma transfusion and plasma/RBC ratios at 4 and 24 hours were improved post-LP implementation with a coinciding reduction in RBC units transfused (p < 0.05). In a 28-day Cox proportional hazards regression LP implementation was associated with favorable recovery (hazard ratio, 3.16; 95% confidence interval, 1.60-6.24; p < 0.001) and reduction in acute kidney injury (hazard ratio, 0.092; 95% confidence interval, 0.011-0.77; p = 0.027). No post-LP patients with blood group type B or AB (n = 9) demonstrated evidence of hemolysis within 24 hours of type A LP transfusion.
CONCLUSION: Initial resuscitation with LP optimizes early plasma administration and improves adherence to transfusion ratio guidelines. Furthermore, LP offers a solution to inherent delays with FFP and is associated with improved clinical outcomes, particularly 28-day recovery and odds of acute kidney injury. Liquid plasma should be considered as an alternative to FFP in MTPs.
LEVEL OF EVIDENCE: Therapeutic/care management, level IV.
参考来源
- Beattie G, Cohan CM, Ng VL, et al. Liquid plasma: A solution to optimizing early and balanced plasma resuscitation in massive transfusion. J Trauma Acute Care Surg. 2020. PMID: 32520899. doi:10.1097/TA.0000000000002822
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。